Search

Your search keyword '"Jouve T"' showing total 127 results

Search Constraints

Start Over You searched for: Author "Jouve T" Remove constraint Author: "Jouve T"
127 results on '"Jouve T"'

Search Results

5. Prélèvement de rein pour transplantation a donneur vivant, suites opératoires et évolution des donneurs. Évaluation bicentrique des pratiques sur 425 cas

6. Corrigendum to “Effect of double-filtration plasmapheresis for antibody-mediated rejection on hemostasis parameters and thrombin generation” [Thromb. Res. 166 (2018) 113–121]

9. French Intensive Care Society, International congress - Réanimation 2016

10. Protein mass spectra data analysis for clinical biomarker discovery

11. Etude des déterminants de la puissance statistique en spectrométrie de masse

16. Tacrolimus CYP3A Single-Nucleotide Polymorphisms and Preformed T- and B-Cell Alloimmune Memory Improve Current Pretransplant Rejection-Risk Stratification in Kidney Transplantation

17. Impaired antigen-specific B-cell responses after Influenza vaccination in kidney transplant recipients receiving co-stimulation blockade with Belatacept

18. A Prospective Multicenter Trial to Evaluate Urinary Metabolomics for Non-invasive Detection of Renal Allograft Rejection (PARASOL): Study Protocol and Patient Recruitment

19. Recurrence of iga nephropathy after kidney transplantation in adults

20. Recurrence of FSGS after Kidney Transplantation in Adults

21. French Intensive Care Society, International congress – Réanimation 2016

22. Corrigendum: Glycolysis Changes in Alloreactive Memory B Cells in Highly Sensitized Kidney Transplant Recipients Undergoing Desensitization Therapy.

23. A Population Pharmacokinetic Model of Tocilizumab in Kidney Transplant Patients Treated for Chronic Active Antibody-Mediated Rejection: Comparison of Plasma Exposure Between Intravenous and Subcutaneous Administration Schemes.

24. High-dimensional mass cytometry identified circulating natural killer T-cell subsets associated with protection from cytomegalovirus infection in kidney transplant recipients.

25. Effects of SLC34A3 or SLC34A1 variants on calcium and phosphorus homeostasis.

26. Glycolysis Changes in Alloreactive Memory B Cells in Highly Sensitized Kidney Transplant Recipients Undergonig Desensitization Therapy.

27. Corrigendum: Impaired antigen-specific B-cell responses after Influenza vaccination in kidney transplant recipients receiving co-stimulation blockade with Belatacept.

28. Calcium-Free Dialysate Hemodialysis: A Simplified Approach.

29. Unraveling complexity: morbidity factors in elderly kidney transplant recipients.

30. Evaluation of Torque Teno Virus DNA Load as a Predictive Biomarker in Kidney Transplant Recipients Converted from Calcineurin Inhibitors to Belatacept.

31. Is There a Place for Apheresis in the Management of Idiopathic Membranous Nephropathy? A Report of Three Cases and Literature Review.

32. Adverse Drug Events after Kidney Transplantation.

33. Early Exposure of Kidney Transplant Recipients with Chronic Antibody-Mediated Rejection to Tocilizumab-A Preliminary Study.

34. Quantification of belatacept by liquid chromatography-tandem mass spectrometry in human plasma: Application to a pharmacokinetic study in renal transplant recipients.

35. Desensitization in Crossmatch-positive Kidney Transplant Candidates.

36. Imlifidase therapy: exploring its clinical uses.

37. Cryoglobulinemia and double-filtration plasmapheresis: Personal experience and literature review.

38. Tocilizumab Evaluation in HLA-Desensitization before Kidney Transplantation as an Add-On Therapy to Apheresis: The TETRA Study.

39. Conversion to mTOR-Inhibitors Plus IV Immunoglobulins in Kidney-Transplant Recipients with BKV Infection: A Retrospective Comparative Study.

40. [Improving access to kidney transplantation for highly sensitized patients: What place for IL-6 pathway blockade in desensitization protocols?]

41. Long-lasting adaptive immune memory specific to SARS-CoV-2 in convalescent coronavirus disease 2019 stable people with HIV.

42. Tacrolimus CYP3A Single-Nucleotide Polymorphisms and Preformed T- and B-Cell Alloimmune Memory Improve Current Pretransplant Rejection-Risk Stratification in Kidney Transplantation.

43. A comprehensive assessment of long-term SARS-CoV-2-specific adaptive immune memory in convalescent COVID-19 Solid Organ Transplant recipients.

44. Tocilizumab and Active Antibody-Mediated Rejection in Kidney Transplantation: A Literature Review.

45. Early Blood Transfusion After Kidney Transplantation Does Not Lead to dnDSA Development: The BloodIm Study.

46. Very Early Severe Posttransplant Recurrent Antineutrophil Cytoplasmic Antibody-Associated Glomerulonephritis after Kidney Transplantation: Two Case Reports.

48. A Prospective Multicenter Trial to Evaluate Urinary Metabolomics for Non-invasive Detection of Renal Allograft Rejection (PARASOL): Study Protocol and Patient Recruitment.

49. Immune responses following tocilizumab therapy to desensitize HLA-sensitized kidney transplant candidates.

50. Tocilizumab Trough Levels Variability in Kidney-Transplant Candidates Undergoing Desensitization.

Catalog

Books, media, physical & digital resources